Yuhan Corporation
UKC 2024 Distinguished Sponsor Forum
Yuhan Corporation
Aug 22nd Thursday, 02:00 PM - 04:00 PM
Location: Sandpebble C
Forum Title: New modalities and tools for innovative oncology drug development
Jae Beom Kim
Chair
Director Alliance Management Gilead Sciences
Hungoo Lee
Co-Chair
Assistant Professor Johns Hopkins School of Medicine(Starting this fall)
Speakers
Taewon Yoon
Yuhan USA Corporation
Kunwoo Lee
GenEdit
Whijae Roh
Pfizer
Jaehak Oh
Amgen
Forum Summary
Yuhan Corporation is a South Korea-based pharmaceutical company founded in 1926 by Dr. Il-han New, an independence activist, educator, and innovative entrepreneur. Yuhan has achieved five out-licensing deals during the past five years, resulting in a total deal size of $3.54 billion. This forum aims to discuss new modalities and tools for innovative oncology drug development. Dr. Kunwoo Lee will talk about mRNA revolution beyond Covid-19 vaccine. Dr. Whijae Roh will present forward and reverse translation between preclinical models and patient samples for iterative drug development process. Dr. Jaehak Oh will discuss the current and future of immune-oncology. By bringing together researchers and experts in the field, this forum seeks to accelerate active discussions and collaborations with esteemed academic researchers.
Forum Schedule
Aug 22nd Thursday